Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections-Reference-Cited by-同舟云学术

Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections

Published:2019-09 Issue:5 Volume:18 Page:714-720
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Banaschewski Brandon,Verma Deepshikha,Pennings Lian J.,Zimmerman Matthew,Ye Qihua,Gadawa Jake,Dartois Veronique,Ordway Diane,van Ingen Jakko^ORCID,Ufer Stefan,Stapleton Kevin,Hofmann Thomas

Funder

Cystic Fibrosis Foundation Therapeutics

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference49 articles.

1. Patient registry annual data report 2018;Cystic Fibrosis Foundation,2017

2. Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis;Martiniano;Ann Am Thorac Soc,2014

3. Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia;Qvist;J Cyst Fibros,2015

4. Comparing the harmful effects of nontuberculous mycobacteria and gram negative bacteria on lung function in patients with cystic fibrosis;Qvist;J Cyst Fibros,2016

5. Nontuberculous mycobacterial infection is associated with increased respiratory failure: a nationwide cohort study;Yeh;PLoS One,2014

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division;International Journal of Antimicrobial Agents;2024-10

2. Advances in diagnosis and treatment of non-tuberculous mycobacterial lung disease;Diagnostic Microbiology and Infectious Disease;2024-06

3. Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products;Current Topics in Medicinal Chemistry;2024-06

4. Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosis;Journal of Controlled Release;2024-05

5. Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model;Antimicrobial Agents and Chemotherapy;2024-03-06